Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Hopkins

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Anesthesiology|April 1, 1992
Inconsistency of data linking the ryanodine receptor and malignant hyperthermia genesP M Hopkins, F R Ellis, P J Halsall
British Journal of Anaesthesia|November 1, 1992
Is the "K-type" caffeine-halothane responder susceptible to malignant hyperthermia?F R Ellis, P J Halsall, P M Hopkins
General Pharmacology|January 1, 1994
The effects of benzamil on in vitro contracture responses of human skeletal muscle to halothaneP M Hopkins, F R Ellis, P J Halsall
Anaesthesia|October 1, 1991
Comparison of high and low doses of suxamethoniumK G Stewart, P M Hopkins, S G Dean
British Journal of Anaesthesia|February 9, 2013
What is the ED95 of prilocaine for femoral nerve block using ultrasound?P K Gupta, S Chevret, S Zohar, et al.
British Journal of Anaesthesia|February 19, 2015
Peripheral regional anaesthesia and outcome: lessons learned from the last 10 yearsJ Kessler, P Marhofer, P M Hopkins, et al.
British Journal of Anaesthesia|June 18, 2002
No evidence of mutations in the CACNA1S gene in the UK malignant hyperthermia populationC Brooks, R L Robinson, P J Halsall, et al.
European Journal of Anaesthesiology|August 30, 2000
Patient-controlled analgesia and urinary retention following lower limb joint replacement: prospective audit and logistic regression analysisJ A O'Riordan, P M Hopkins, A Ravenscroft, et al.
Anesthesiology|October 31, 2001
Halothane inhibits contraction and action potential duration to a greater extent in subendocardial than subepicardial myocytes from the rat left ventricleA Rithalia, C N Gibson, P M Hopkins, et al.
British Journal of Anaesthesia|September 1, 1990
Muscle relaxation rates in individuals susceptible to malignant hyperthermiaA Urwyler, F R Ellis, P J Halsall, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Anesthesiology|April 1, 1992
Inconsistency of data linking the ryanodine receptor and malignant hyperthermia genesP M Hopkins, F R Ellis, P J Halsall
British Journal of Anaesthesia|November 1, 1992
Is the "K-type" caffeine-halothane responder susceptible to malignant hyperthermia?F R Ellis, P J Halsall, P M Hopkins
General Pharmacology|January 1, 1994
The effects of benzamil on in vitro contracture responses of human skeletal muscle to halothaneP M Hopkins, F R Ellis, P J Halsall
Anaesthesia|October 1, 1991
Comparison of high and low doses of suxamethoniumK G Stewart, P M Hopkins, S G Dean
British Journal of Anaesthesia|February 9, 2013
What is the ED95 of prilocaine for femoral nerve block using ultrasound?P K Gupta, S Chevret, S Zohar, et al.
British Journal of Anaesthesia|February 19, 2015
Peripheral regional anaesthesia and outcome: lessons learned from the last 10 yearsJ Kessler, P Marhofer, P M Hopkins, et al.
British Journal of Anaesthesia|June 18, 2002
No evidence of mutations in the CACNA1S gene in the UK malignant hyperthermia populationC Brooks, R L Robinson, P J Halsall, et al.
European Journal of Anaesthesiology|August 30, 2000
Patient-controlled analgesia and urinary retention following lower limb joint replacement: prospective audit and logistic regression analysisJ A O'Riordan, P M Hopkins, A Ravenscroft, et al.
Anesthesiology|October 31, 2001
Halothane inhibits contraction and action potential duration to a greater extent in subendocardial than subepicardial myocytes from the rat left ventricleA Rithalia, C N Gibson, P M Hopkins, et al.
British Journal of Anaesthesia|September 1, 1990
Muscle relaxation rates in individuals susceptible to malignant hyperthermiaA Urwyler, F R Ellis, P J Halsall, et al.
Pageof 13